Felix Geissler
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Felix Geissler
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Felix Geissler
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
XOMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
HUMANIGEN, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
XENCOR, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
GENOCEA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Director/Board Member | |
Grifols, Inc.
Grifols, Inc. Pharmaceuticals: MajorHealth Technology Grifols, Inc. manufactures pharmaceuticals. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree | |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boston College | College/University | Graduate Degree | |
Colby College | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Corporate Officer/Principal | |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree | |
St. Louis University | College/University | Doctorate Degree | |
University of California San Diego | College/University | Undergraduate Degree | |
University of Illinois | College/University | Undergraduate Degree | |
DNAX Research, Inc. | Corporate Officer/Principal | ||
ACT Biotech, Inc.
ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of California | College/University | Corporate Officer/Principal | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
LOXO ONCOLOGY INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member | |
Stritch School of Medicine | College/University | Doctorate Degree | |
ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member | |
HARPOON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
BIOVERATIV INC | Biotechnology | Comptroller/Controller/Auditor | |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Director/Board Member | |
Lak505, LLC | Corporate Officer/Principal | ||
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Kalobios Pharmaceuticals, Inc. | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 49 |
Spanien | 2 |
Irland | 2 |
Sektoral
Health Technology | 37 |
Consumer Services | 11 |
Retail Trade | 2 |
Operativ
Corporate Officer/Principal | 21 |
Director/Board Member | 15 |
Chief Tech/Sci/R&D Officer | 11 |
Independent Dir/Board Member | 7 |
Undergraduate Degree | 5 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Lori Kunkel | 27 |
Anne Borgman | 13 |
Diantha Duvall | 8 |
William Steinkrauss | 4 |
Kimberly Steinmann | 3 |
- Börse
- Insiders
- Felix Geissler
- Unternehmensverbindungen